Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma C Morris

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Blood|May 22, 2025
Haploidentical HSCT: more curative options for patients with CGDEmma C Morris
Blood|January 20, 2018
Editing gene engineering to enhance functionEmma C Morris
Nature Immunology|July 11, 2020
Engineered T cells Flt around their targetsEmma C Morris
Hematology. American Society of Hematology. Education Program|December 4, 2020
Allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiencyEmma C Morris
Blood|September 4, 2020
HCT for CGD? Yes, and the sooner the betterEmma C Morris
Best Practice & Research. Clinical Haematology|February 8, 2005
Reduced intensity allogeneic stem cell transplantation for low grade non-Hodgkin's lymphomaEmma C Morris, Stephen Mackinnon
Blood|June 2, 2021
How I use allogeneic HSCT for adults with inborn errors of immunitySiobhan O Burns, Emma C Morris
Blood|May 22, 2016
Optimizing T-cell receptor gene therapy for hematologic malignanciesEmma C Morris, Hans J Stauss
Frontiers in Pediatrics|November 12, 2019
Allogeneic HSCT in Adolescents and Young Adults With Primary ImmunodeficienciesEmma C Morris, Michael H Albert
Immunology|June 22, 2010
Molecular immunology lessons from therapeutic T-cell receptor gene transferSharyn Thomas, Hans J Stauss, Emma C Morris
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Blood|May 22, 2025
Haploidentical HSCT: more curative options for patients with CGDEmma C Morris
Blood|January 20, 2018
Editing gene engineering to enhance functionEmma C Morris
Nature Immunology|July 11, 2020
Engineered T cells Flt around their targetsEmma C Morris
Hematology. American Society of Hematology. Education Program|December 4, 2020
Allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiencyEmma C Morris
Blood|September 4, 2020
HCT for CGD? Yes, and the sooner the betterEmma C Morris
Best Practice & Research. Clinical Haematology|February 8, 2005
Reduced intensity allogeneic stem cell transplantation for low grade non-Hodgkin's lymphomaEmma C Morris, Stephen Mackinnon
Blood|June 2, 2021
How I use allogeneic HSCT for adults with inborn errors of immunitySiobhan O Burns, Emma C Morris
Blood|May 22, 2016
Optimizing T-cell receptor gene therapy for hematologic malignanciesEmma C Morris, Hans J Stauss
Frontiers in Pediatrics|November 12, 2019
Allogeneic HSCT in Adolescents and Young Adults With Primary ImmunodeficienciesEmma C Morris, Michael H Albert
Immunology|June 22, 2010
Molecular immunology lessons from therapeutic T-cell receptor gene transferSharyn Thomas, Hans J Stauss, Emma C Morris
Pageof 8